Skip to Main Content

Author Details

Bert A van der Reijden
1993
129
38
PMIDPaper TitleJournal TitlePublished Year
37190104Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.2023
37731314BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.2023
37720253Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort.2023
37713242Improvement, Implementation, and Evaluation of the CMyLife Digital Care Platform: Participatory Action Research Approach.2023
37632778Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.2023
36713353Sex Differences in the Spectrum of Clonal Hematopoiesis.2023
37146604Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population.Cancer Cell2023
36890512Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial.2023
36698617Abnormal Platelet Counts and Clonal Hematopoiesis in the General Population.2023
36807648High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia.2023
35024892Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML.Annals of Hematology2022
35561316Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals.Blood Adv2022
347245632021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.Blood2021
33690840Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders.Blood2021
33725274Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway.2021
33877299Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged â¿¥80 years.Blood advances2021
33496751Neutrophil specific granule and NETosis defects in gray platelet syndrome.Blood Adv2021
33359455Multicenter Next-Generation Sequencing Studies between Theory and Practice: Harmonization of Data Analysis Using Real-World Myelodysplastic Syndrome Data.J Mol Diagn2021
34459888Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality.Blood Adv2021
34450246Characterization of a genomic region 8 kb downstream of GFI1B associated with myeloproliferative neoplasms.2021
33054062Transcription factor 4 () expression predicts clinical outcome in mutated and translocated acute myeloid leukemia.Haematologica2020
32243522Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals.Blood2020
32124467Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB.American Journal of Hematology2020
32730581A collapse for venous thromboembolism.Blood2020
30673601Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes.Cell Rep2019
31649884Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.Frontiers in Oncology2019
30315825TCF4 promotes erythroid development.Experimental Hematology2019
30431218Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis.Haemophilia2019
30573501Inherited missense variants that affect GFI1B function do not necessarily cause bleeding diatheses.Haematologica2019
30655368Molecular mechanisms of bleeding disorderassociated GFI1B mutation and its affected pathways in megakaryocytes and platelets.Haematologica2019
30850577CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1.Blood Cancer Journal2019
29330221Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.Blood2018
28983057Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.Haematologica2018
28871137C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.Leukemia2018
29945233appreci8: a pipeline for precise variant calling integrating 8 tools.Bioinformatics2018
29674496GFI1 is required for <i>RUNX1/ETO</i> positive acute myeloid leukemia.Haematologica2018
29311096Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT.Blood2018
28114278MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.Oncogene2017
28429724Clonal evolution in myelodysplastic syndromes.Nat Commun2017
29055225Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.Stem Cell Research2017
28395797Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.Stem Cell Res2017
27416910Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.Leukemia2017
28280089Successful Transfer of Umbilical Cord Blood CD34 Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients.Clinical Cancer Research2017
28236351Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.Genes Chromosomes and Cancer2017
28222155GLM-based optimization of NGS data analysis: A case study of Roche 454, Ion Torrent PGM and Illumina NextSeq sequencing data.PLoS ONE2017
28233799Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data.Scientific Reports2017
28096094Platelet CD34 expression and α/δ-granule abnormalities in - and -related familial bleeding disorders.Blood2017
27902785Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients.PLoS One2016
27080012GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.Exp Hematol2016
255791745-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.2015
  • 1 - 50 of 129

Recommended Authors

Collaborators

Co-authored papers 94
Co-authored papers 11
University Hospital of Muenster
Co-authored papers 6
University of Pavia & S. Matteo Hospital
Co-authored papers 6
Institut de recherches cliniques de Montreal
Co-authored papers 6
Co-authored papers 6
University Medical Center Utrecht
Co-authored papers 6
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 5
Co-authored papers 4
Radboud University Medical Center
Co-authored papers 4
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 4
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 3
Co-authored papers 3
University of Cambridge
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Hannover Medical School
Co-authored papers 2
Center for Molecular and Vascular Biology, University of Leuven
Co-authored papers 2
European Bioinformatics Institute
Co-authored papers 2
Co-authored papers 2
and Blood Institute, National Institutes of Health
Co-authored papers 2
Kyoto University
Co-authored papers 2
Tokyo Medical and Dental University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Co-authored papers 2
Max Planck Institute for Molecular Genetics
Co-authored papers 2